An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

Clinical trial NCT01256372 · COMPLETED

Trial details

NCT number: NCT01256372
Sponsor: Action Pharma A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiac Surgery Coronary Artery Bypass Aortic Aneurysm Valve Surgery Kidney Diseases

Start date: 2010-10-01
Primary completion: 2011-06-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.